Emergent BioSolutions Inc. — Director's Dealing 2016

Mar 15, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2016-03-11

Reporting Person: Havey Adam (EVP, Biodefense Divison)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-03-11	Common Stock	M	7960	$14.67	Acquired	54254	Direct
2016-03-11	Common Stock	S	7960	$33.84	Disposed	46294	Direct
2016-03-11	Common Stock	S	3152	$33.84	Disposed	43142	Direct
2016-03-11	Common Stock	F	1278	$34.22	Disposed	41864	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-03-11	Stock Option	$14.67	M	7960	Acquired	2020-03-11	Common Stock (7960)	Direct

Footnotes

F1: Consists of an option granted under the company's stock incentive plan on March 12, 2013.

F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey.

F3: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.56 to $34.14, inclusive.

F4: Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended.

F5: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.56 to $34.09, inclusive.

F6: The option vest in three equal installments in March 2014, 2015 and 2016.